Dr. George Yancopoulos, CSO of Regeneron $REGN on efficacy of Kevzara (a rheumatoid arthritis drug) relative to #COVID19 — “The history of repurposing existing drugs is not really a very fruitful one.”

$SPX $ES_F #COVID19 @CNBC